Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANVS

Annovis Bio Inc

May 07 • 09:34AM ET

2.39

-0.01 -0.21 %

Healthcare • Biotechnology • USA • Micro • NYSE

Peers: BIIB ACAD AXSM FLNA NBIX AVXL NERV PRTA PRQR RNA

| Held by: VTI VXF DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.40	Insider Own	16.96%	Shs Outstand	34.53M	Perf Week	21.57%
Market Cap	82.71M	Forward P/E	-	EPS next Y	-1.31	Insider Trans	48.25%	Shs Float	28.68M	Perf Month	4.13%
Enterprise Value	63.18M	PEG	-	EPS next Q	-0.40	Inst Own	15.14%	Short Float	16.60%	Perf Quarter	-1.84%
Income	-28.85M	P/S	-	EPS this Y	9.64%	Inst Trans	12.40%	Short Ratio	6.02	Perf Half Y	26.72%
Sales	0.00M	P/B	3.87	EPS next Y	-3.56%	ROA	-164.85%	Short Interest	4.76M	Perf YTD	-30.78%
Book/sh	0.62	P/C	4.23	EPS next 5Y	-8.94%	ROE	-220.61%	52W High	5.50 -56.45%	Perf Year	51.58%
Cash/sh	0.57	P/FCF	-	EPS past 3/5Y	23.23% -10.15%	ROIC	-171.23%	52W Low	1.44 66.32%	Perf 3Y	-83.30%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.80% 8.39%	Perf 5Y	-89.80%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	27.86%	Oper. Margin	-	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.80	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	63.31	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.80	EPS Q/Q	17.04%	SMA20	24.56%	Beta	1.32	Target Price	12.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	7.67%	Rel Volume	0.65	Prev Close	2.40
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 16 BMO	SMA200	-9.95%	Avg Volume	790.16K	Price	2.39
IPO	Jan 29, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-26.46% -	Trades		Volume	30,671	Change	-0.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)